Press Release Summary:
Nano Bot™ Device is designed for monitoring and conveying environmental data critical to human health and digital control. The unit is embedded with Arm based microcontroller and array of environmental sensors. The data provided by the Nano Bot helps to understand, predict, and rectify threats such as antimicrobial resistance (AMR) and superbugs.
Original Press Release:
Nano Global Announces First Generation Nano Bot™
Arm-Powered Device to Drive Human Health and Disease Control
AUSTIN, Texas, May 08, 2018 – Nano Global (“Nano”), an Austin, Texas-based company focused on accelerating cures to address global health challenges, today announced plans for a limited release of its first generation Nano Bot™ device to monitor and convey environmental data critical to human health and disease control.
The first generation Nano Bot™, featuring an Arm based microcontroller and array of environmental sensors, will be deployed initially at healthcare and research facilities operated by some of Nano’s close strategic partners. This marks an important milestone in Nano’s ability to monitor sensitive environments for health threats by collecting ambient environmental information to better understand, predict, and rectify threats such as antimicrobial resistance (AMR) and superbugs. Data acquired through Nano Bots™ provides an important data stream to the company’s broader data-driven artificial intelligence (AI) platform called Nano Sense™.
“Implementing this technology in healthcare facilities aligns perfectly with our mission to provide the best care for patients while furthering important research to better understand how our environment creates and contributes to health threats,” said Dr. Peter J. Hotez, M.D., Ph.D., professor of pediatrics and molecular virology & microbiology at Baylor College of Medicine, director of Texas Children’s Hospital Center for Vaccine Development and U.S. Science Envoy.
The company’s Nano Sense™ system-on-chip (SoC) , currently under development in partnership with Arm, (https://nanoglobal.com/press-releases/nano-arm-collaborate-on-artificial-intelligence-chip/) will power future Nano Bot™ and partner devices to enable data acquisition and AI at the edge, accelerating detection, prevention, and treatment of health threats.
“For Nano and its affiliates, the release of our first-generation Nano Bot™ device signals an important step in our mission to help fight global health threats,” said Steve Papermaster, chairman and CEO of Nano. “We believe our technology platform is a game-changer for detecting and understanding critical elements of health and look forward to building on this exciting momentum.”
About Nano Global
Nano Global is focused on accelerating cures to address global health challenges. The company’s technology platform, which includes a series of chips being developed in partnership with Arm, ( www.arm.com/ ) will add an entirely new dimension to existing global datasets: from molecular data, to cellular, patient level, population health and environmental data, collected in real-time. Learn more about Nano Global at www.nanoglobal.com.
As an affiliate partner, Nano Vision ( nanovision.com/ ) will leverage this technology platform to enable a global, decentralized data marketplace and intelligence platform to enhance the efficiency of medical discovery and break down traditional barriers that hinder progress. Learn more about Nano Vision at www.nanovision.com.
Rob Ashwell / Oliver Davies
firstname.lastname@example.org, +44 1225 470000
In house contact: